Shots:
- GE HealthCare’s MINItrace Magni cyclotron has received CE Mark; the compact, self-shielded system with automated operation is designed to produce Fluorine-18, Carbon-11, Oxygen-15 & Nitrogen-13 radioisotopes for PET tracers, supporting local, in-house radioisotope production
- MINItrace Magni features an intuitive user interface, a three-click workflow and automated features incl. auto-tuning, which prepares the cyclotron & targets, tunes the beam and manages target irradiation; it is designed to be used with TRACERcenter Solutions to support a broader PET radiopharmacy workflow
- The company also expanded its PETtrace Solid Target Platform beyond Gallium-68 (introduced in 2022) and Zirconium-89 (early 2026) with support for Copper-64 production, supporting research into copper-based imaging agents & the potential Copper-64/Copper-67 theranostic pair
Ref: GE HealthCare | Image: GE HealthCare | Press Release
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
